4/20/2023 0 Comments Mostrecent bkllf stock priceMydecine Health Sciences, Mindleap Health, and NeuroPharm make up the group dedicated to developing psychedelic products for treating a variety of ailments. Mydecine Innovations Group (CSE:MYCO) Vancouver, British Columbia Tackling opioid addiction with psychedelics is top priority for MindMed and it’s being hailed as one of the hottest stocks in the market after its recent partnership with Johns Hopkins. Mind Medicine (MindMed) (NEO:MMED,OTCQB:MMEDF) Toronto, Ontario It’s working to develop natural health products. While rooted in cannabis, Hollister acquired psilocybin-focused AlphaMind Brands. Hollister Biosciences (CSE:HOLL,OTC Pink:HSTRF) Vancouver, British Columbia With an exemption from Health Canada, it’s able to research and develop psilocybin-based products for scientific use, developing compounds for natural health products. Havn Life Sciences (CSE:HAVN) Vancouver, British Columbia With the Eleusian Biosciences acquisitions it is expanding research and therapy options through a unique combination of N-Acetylcysteine and psilocybin. GreenStar Biosciences (CSE:GSTR,OTC Pink:GTSIF), Vancouver, British Columbia Its recent acquisition of Shroom Street puts it in position to combine tech and treatment. Graph Blockchain (CSE:GBLC)Richmond, British Columbia Integrating media, creativity, and technology around psychedelics, it owns and operates Psychedelic Spotlight. Global Trac Solutions (OTC Pink: PSYC) San Diego, California Andrew Weil now on its advisory board, Field Trip is normalizing psychedelic therapies. Field Trip Health (CSE:FTRP) Toronto, Ontario Compass Pathways (NASDAQ:CMPS), United KingdomĪ research giant focused on depression treatments by way of psychedelics. Codebase Ventures (CSE:CODE,OTCQB:BKLLF), Vancouver, British ColumbiaĪn investment firm with opportunities in psilocybin and microdose enterprise Titan Shrooms & Psychedelics. Clarify Pharma (AQSE: PSYC.PL.) London, EnglandĪn investment platform focused on biotech and life sciences companies with an interest in advancing psychedelic medicine. It’s working with a number of psychedelics and plans to open clinics for psychedelic treatments. Champignon Brands (CSE:SHRM,OTCQB:SHRMF) Port Moody, British Columbia Better Plant Sciences (CSE:PLNT,OTCQB:VEGGF), Vancouver, British ColumbiaĪ wellness-focused firm that has taken a majority ownership stake in NeonMind Biosciences, which is working on psilocybin research. Its psilocybin-based drug was as effective as the antidepressant Lexapro in clinical trials. Atai Life Sciences (NASDAQ: ATAI), Berlin, GermanyĪ biopharmaceutical company working with a number of substances to treat mental health issues. It’s currently a cannabis company, but plans include crossing over into psychedelics, 2. Aion Therapeutic (CSE:AION), Toronto, Ontario Public Psychedelic Companies (alphabetical) 1. This list of companies shows a strong presence in the Canadian market. The EU is seeing research and product expansion as is Canada. making psychedelics a ripe investing platform. Cities including Denver, Washington D.C., Ann Arbor, Mich., and Oakland and Santa Cruz in California have all passed similar decriminalization laws.īut it isn’t just the U.S. Oregon became the first state to legalize psychedelics in clinical settings as well as decriminalizing personal use and possession. Legislation and the decriminalization of psychedelics is moving the needle ahead as well. She says the companies that will dominate the market “will have deep pockets, patentable products and a well-thought-out reimbursement strategy.” Tania Gonsalves, analyst for Canaccord Genuity Capital Markets, notes that the market value for psychedelic therapies - which are less costly than conventional drug-based treatments - could be as high as $100 billion. “The Food and Drug Administration has approved and fast-tracked several clinical research trials.” “Decades of research have demonstrated that psychedelics, which are hallucinogenic drugs, are effective in treating mental disorders such as depression, suicidal thoughts, PTSD and anxiety,” Ellen Chang wrote in U.S. And the research is showing promise these substances appear to treat a number of mental health issues better than some conventional therapies. Researchers have been exploring the benefits of psychedelics for decades. Thinking about investing in psychedelics? Experts say it could be a smart move.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |